A new review conducted by researchers at the Universities of Birmingham and Oxford suggests that nitrous oxide, commonly known as laughing gas, may provide significant and rapid relief for individuals suffering from major depressive disorder. This discovery is particularly promising for those who have not found relief from other treatments, both pharmaceutical and non-pharmaceutical.
The findings, set to be published in eBioMedicine, are based on an analysis of seven clinical trials involving a total of 247 participants. In these trials, volunteers inhaled either 25 percent or 50 percent nitrous oxide, while control groups were given placebos. Results indicated that the higher dosage was more effective in alleviating depressive symptoms, although it was accompanied by side effects such as nausea, headaches, and a sensation described by some participants as an out-of-body experience.
Despite these side effects, the speed at which nitrous oxide alleviated depressive symptoms was notable. Participants reported significant improvements within just two hours of inhalation. Although the relief was temporary, typically diminishing within a week unless treatments were continued, the rapid onset of effects places nitrous oxide in a similar category as ketamine, another treatment known for its quick action on depression.
Researchers hypothesize that nitrous oxide may exert its effects by modulating the brain’s glutamatergic system, a neural communication network that has been linked to depression. Additionally, nitrous oxide’s ability to increase blood flow could enhance nutrient cycling in the brain, potentially helping to eliminate harmful chemicals that contribute to depressive symptoms. This process can be likened to a thorough cleansing of the brain, improving its overall function.
While these early findings are encouraging, the researchers emphasize the need for further investigation before nitrous oxide can be routinely recommended for individuals with severe depression. More research is essential to fully understand the long-term effects and potential risks associated with its use as a treatment.
The exploration of nitrous oxide as a therapeutic option highlights the ongoing search for effective treatments for depression, particularly for those who have not benefited from conventional therapies. As we gain more insights into its mechanisms and efficacy, this research could pave the way for new approaches to mental health care.
